Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Emergent BioSolutions Inc.
Emergent BioSolutions announced that CFO Richard Lindahl will retire effective December 31, 2026. Frank Vargo, Vice President and Treasurer, will assume the role of interim CFO starting January 1, 2027, with Lindahl serving as a senior executive advisor through March 31, 2027, to ensure a smooth transition.…more
Emergent BioSolutions Inc.
Donald W. DeGolyer, an insider at Emergent BioSolutions Inc., has filed an SEC Form 144 to report a proposed sale of company shares. This is a standard filing disclosing the insider's plan to dispose of their holdings.…more
Emergent BioSolutions Inc.
Insider Donald W. DeGolyer of Emergent BioSolutions Inc. filed a Form 4 statement regarding changes in beneficial ownership of securities on October 7, 2026. This filing discloses the insider's transaction activity, providing transparency into the company's governance and insider holdings.…more
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Emergent Biosolutions Appoints Frank Vargo as Interim CFO
Emergent Biosolutions has appointed Treasurer Frank Vargo as the interim CFO, succeeding Richard Lindahl. The appointment is set to take effect on January 1, 2027.…more
●●●●●●●● ●●●●● ●●●●●●
Russian authorities have officially denied media reports regarding a second case of illness in the Siberia region. This development does not contain specific economic data or corporate information that would impact the markets.…more
●●●●●●●● ●●●●● ●●●●●●
Emergent BioSolutions will hold a ribbon-cutting ceremony to mark the restart and expansion of its manufacturing facility in Canton, Massachusetts. The company plans to create approximately 50 new jobs as part of its investment in advanced biopharmaceutical manufacturing.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.